TY - JOUR
T1 - Progressive Reduction of Visual P300 Amplitude in Patients with First-Episode Schizophrenia
T2 - An ERP Study
AU - Oribe, Naoya
AU - Hirano, Yoji
AU - Kanba, Shigenobu
AU - Del Re, Elisabetta
AU - Seidman, Larry
AU - Mesholam-Gately, Raquelle
AU - Goldstein, Jill M.
AU - Shenton, Martha
AU - Spencer, Kevin M.
AU - McCarley, Robert W.
AU - Niznikiewicz, Margaret
N1 - Publisher Copyright:
© 2014 The Author 2014. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.
PY - 2015/3/1
Y1 - 2015/3/1
N2 - Objective: To understand the underlying dynamic neurophysiological changes over the course of schizophrenia, it is important to study subjects longitudinally from the early stage of the illness. We previously reported that visual P300 was already impaired in patients with first-episode schizophrenia (FESZ). This study demonstrates how the visual P300, as well as earlier components P1, N1, and N200, changed at the 1-year follow-up after their initial measurement. Methods: Visual ERPs were recorded with the same experimental paradigm and acquisition protocol at both time points in FESZ (n = 18) and healthy comparison subjects (n = 24). Participants silently counted infrequent target stimuli ("x") amid standard stimuli ("y") presented on the screen while the 64-channel electroencephalogram was recorded. Results: FESZ showed smaller visual P300, N200, P1 (trend level) amplitude and delayed P300 and N1 latency at both time points; however, only P300 showed progressive amplitude reduction over the course of the illness at 1-year follow-up. P300 latency did not change over time in either group. FESZ showed significantly reduced Spatial Span total score at both time points, and there was a significant negative correlation between P300 peak amplitude and the Brief Psychiatric Rating Scale positive symptom score at baseline. Conclusion: These data show progressive P300 amplitude reduction in response to visual stimuli in the early stage of schizophrenia. These visual P300 findings support the concept of progression of schizophrenia, suggesting the usefulness of the visual P300 as a biological marker of progression.
AB - Objective: To understand the underlying dynamic neurophysiological changes over the course of schizophrenia, it is important to study subjects longitudinally from the early stage of the illness. We previously reported that visual P300 was already impaired in patients with first-episode schizophrenia (FESZ). This study demonstrates how the visual P300, as well as earlier components P1, N1, and N200, changed at the 1-year follow-up after their initial measurement. Methods: Visual ERPs were recorded with the same experimental paradigm and acquisition protocol at both time points in FESZ (n = 18) and healthy comparison subjects (n = 24). Participants silently counted infrequent target stimuli ("x") amid standard stimuli ("y") presented on the screen while the 64-channel electroencephalogram was recorded. Results: FESZ showed smaller visual P300, N200, P1 (trend level) amplitude and delayed P300 and N1 latency at both time points; however, only P300 showed progressive amplitude reduction over the course of the illness at 1-year follow-up. P300 latency did not change over time in either group. FESZ showed significantly reduced Spatial Span total score at both time points, and there was a significant negative correlation between P300 peak amplitude and the Brief Psychiatric Rating Scale positive symptom score at baseline. Conclusion: These data show progressive P300 amplitude reduction in response to visual stimuli in the early stage of schizophrenia. These visual P300 findings support the concept of progression of schizophrenia, suggesting the usefulness of the visual P300 as a biological marker of progression.
UR - http://www.scopus.com/inward/record.url?scp=84940823338&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84940823338&partnerID=8YFLogxK
U2 - 10.1093/schbul/sbu083
DO - 10.1093/schbul/sbu083
M3 - Article
C2 - 24914176
AN - SCOPUS:84940823338
SN - 0586-7614
VL - 41
SP - 460
EP - 470
JO - Schizophrenia Bulletin
JF - Schizophrenia Bulletin
IS - 2
ER -